Advertisement
ADVANCED SEARCH

This Article Figures Only Full Text Full Text (PDF) Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garcia, A. Articles by Zanibbi, K. Search for Related Content PubMed PubMed Citation Articles by Garcia, A. Articles by Zanibbi, K. Related Collections Dementia

Homocysteine and cognitive function in elderly people

The authors are with the Department of Medicine, Queen's University, Kingston, Ont.

Abstract

DEMENTIA IS HIGHLY PREVALENT AMONG ELDERLY PEOPLE, and projections show that the number of people affected might triple over the next 50 years, mainly because of a large increase in the oldest-old segment of the population. Because of this and the disease's devastating effects, measures for the prevention and early detection of dementia are crucial. Age and years of education are among the most relevant risk factors for dementia, but in recent years the role of homocysteine has also been investigated. Homocysteine is an amino acid produced in the metabolism of methionine, a process dependent on the B vitamins cobalamin, vitamin B₆ and folic acid. There is evidence that increased serum homocysteine levels are associated with declining cognitive function and dementia. We review this evidence in addition to the potential mechanisms through which homocysteine acts on the brain to cause cognitive dysfunction, the metabolism of homocysteine and factors associated with alteration of the normal metabolism.

This article has been cited by other articles:

				H. Fillit, G. Hess, J. Hill, P. Bonnet, and C. Toso IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders Neurology, July 21, 2009; 73(3): 180 - 185. [Abstract] [Full Text] [PDF]

				J G Z van Uffelen, M J M Chinapaw, W van Mechelen, and M Hopman-Rock Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial Br. J. Sports Med., May 1, 2008; 42(5): 344 - 351. [Abstract] [Full Text] [PDF]

				G. Raman, A. Tatsioni, M. Chung, I. H. Rosenberg, J. Lau, A. H. Lichtenstein, and E. M. Balk Heterogeneity and Lack of Good Quality Studies Limit Association Between Folate, Vitamins B-6 and B-12, and Cognitive Function J. Nutr., July 1, 2007; 137(7): 1789 - 1794. [Abstract] [Full Text] [PDF]

				R. Obeid, P. Kostopoulos, J.-P. Knapp, M. Kasoha, G. Becker, K. Fassbender, and W. Herrmann Biomarkers of Folate and Vitamin B12 Are Related in Blood and Cerebrospinal Fluid Clin. Chem., February 1, 2007; 53(2): 326 - 333. [Abstract] [Full Text] [PDF]

				M. S. Morris, P. F Jacques, I. H Rosenberg, and J. Selhub Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification Am. J. Clinical Nutrition, January 1, 2007; 85(1): 193 - 200. [Abstract] [Full Text] [PDF]

				S. E. Vollset and P. M. Ueland B vitamins and cognitive function: do we need more and larger trials? Am. J. Clinical Nutrition, May 1, 2005; 81(5): 951 - 952. [Full Text] [PDF]

				J. B. J. van Meurs and A. G. Uitterlinden Homocysteine and Fracture Prevention JAMA, March 2, 2005; 293(9): 1121 - 1122. [Full Text] [PDF]

eLetters:

HOME	CURRENT ISSUE	PAST ISSUES	COLLECTIONS	HELP	SEARCH
Copyright 1995-2004, Canadian Medical Association. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p) All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.